Meredith Cook
General Counsel at ANI PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 29/04/2024
Meredith Cook active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ANI PHARMACEUTICALS, INC. | General Counsel | 17/07/2022 | - |
| Corporate Secretary | 17/07/2022 | - |
Career history of Meredith Cook
Former positions of Meredith Cook
| Companies | Position | Start | End |
|---|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
Training of Meredith Cook
| Princeton University | Undergraduate Degree |
| Tulane University Law School | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| General Counsel | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Meredith Cook
- Experience
